Objective. To investigate the effects of an anti-platelet drug (clopidogrel) on the prevention of steroidinduced osteonecrosis (ON) in rabbits.
Introduction
Osteonecrosis (ON) has been reported to occur in patients who have received CS treatment for underlying diseases such as SLE and renal transplantation [1] . The natural history of untreated ON of the femoral head generally involves a progressive collapse that often requires surgical treatments. Therefore, the prevention of ON is an optional strategy for such patients.
The precise pathogenesis of CS-induced ON remains unclear. Several possible factors involved in the pathogenesis of ON have been suggested based on human and animal studies, including coagulation abnormalities, hyperlipidaemia, oxidative stress and endothelial dysfunction [26] . These factors were thought to be related to an interruption of the bone vascular supply and result in bone ischaemia. In some arterial ischaemic events, including cardiovascular diseases and brain strokes, many reports have demonstrated the crucial role of platelet aggregation resulting from dysfunction of the endothelium [7] . Anti-platelet drugs have therefore been widely used to prevent these ischaemic events. However, to our knowledge, there have been no studies assessing the effects of an anti-platelet drug for the prevention of steroid-induced ON.
Adenosine diphosphate (ADP) released from damaged vessels and red blood cells induces platelet aggregation through activation of glycoprotein IIb and IIIa and adhesion using von Willebrand factor. Clopidogrel is a novel anti-platelet drug that selectively and irreversibly inhibits the binding of ADP to its receptor on platelets [8] . Several studies have reported the efficacy and safety of clopidogrel compared with aspirin or ticlopidine in reducing of the risk of ischaemic events [9, 10] . We therefore examined whether clopidogrel could reduce the risk of steroid-induced ON in an experimental rabbit model and evaluated how CSs and clopidogrel influence haematological parameters.
Methods
We utilized a rabbit model of steroid-induced ON [2] . All experiments were conducted in accordance with the Guidelines for Animal Experiments Committee of our institution, Japanese law (no. 105), and notification (no. 6) of the Japanese government.
Animals
We studied 65 adults (defined as animals with closed growth plates) male Japanese white rabbits (Kyudo, Saga, Japan) ranging in age from 28 to 32 weeks. The mean (S.D.) body weight of rabbits was 3490 (180) g. Animals were housed at the Animal Center of Kyushu University and maintained on a standard laboratory diet and water.
Treatment
The rabbits were randomly divided into two groups as follows: one group received 5 mg/kg of body weight of clopidogrel (Sanofi-Aventis, Paris, France) mixed with normal saline (5 ml/kg/day), which was administered intra-gastrically through a rubber gastric tube into the stomach (AP group; n = 35). The other group received normal saline alone (5 ml/kg/day) intra-gastrically (NS group; n = 30). All rabbits were given the drug or normal saline once daily for 3 weeks. One week after the initiation of the study, all rabbits were injected intramuscularly into the right gluteus medius muscle with 20 mg/kg of body weight of methylprednisolone acetate (MPSL; Pfizer, New York, NY, USA). Three weeks after the administration of drugs, all rabbits were killed and tissue specimens were prepared as previously described [2] . The steroid-induced ON rabbit model has been reported to be reproduced precisely [25, 11, 12] .
Evaluation of ON
The diagnosis of ON was determined at 3 weeks after the administration of drugs (2 weeks after the steroid injection) as previously reported [3, 5, 11, 12] . The specimens stained with haematoxylin and eosin, which were obtained from the proximal one-third and distal condyle of both the femora and humeri (eight regions), were examined histologically for the presence of ON. The presence of ON was assessed blindly by four authors (R.Y., T.Y., G.M. and S.I.) [2, 3, 12] on the basis of the presence of diffuse empty lacunae or pyknotic nuclei of osteocytes within the bone trabeculae, accompanied by surrounding bone marrow cell necrosis. If the diagnoses differed between the four investigators, a consensus was reached by discussion of the histological findings without knowledge of the group from which the specimen was obtained. Rabbits with at least one ON lesion among the eight areas were therefore considered to have ON.
Platelet aggregation assay
To examine the anti-platelet effect of clopidogrel, heparinized rabbit whole-blood samples at 03 weeks after the initiation of treatment were measured according to the screen filtration pressure method using WBA Carna (IMI, Saitama, Japan) [13] . The samples (200 ml) in reaction tubes were stirred at 5 g and incubated for 1 min at 40 C, then with 22.2 ml of ADP (LMS, Tokyo, Japan) solution for 2 min at 40 C. Using a 3.7-mm-diameter syringe containing screen microsieves made of nickel, with 300 openings of 20 Â 20 mm 2 in a 0.8-mm diameter area, the samples were placed under a vacuum to detect aggregation pressure at a rate of 200 ml/6.4 s. The pressure rates (%) were measured in four concentrations of ADP (final concentration = 0, 1.0, 4.0 and 16.0 mM). The concentration of ADP causing a 50% increase in the pressure rate was calculated and applied as the platelet aggregation threshold index (PATI), which indicates the anti-platelet effect of drugs.
Examination of laboratory data
We collected 5 ml of blood samples from the auricular arteries while the animals were in a fasting state in the early morning. Samples were obtained just before the initiation of anti-platelet drug or normal saline treatment (Week 0) and at Weeks 1, 2 and 3 after the beginning of treatment. Biochemical and haematological evaluations were made for plasma levels of triglycerides and total cholesterol, as well as number of platelets.
Statistical analysis
Data were expressed as the means (S.D.). The numbers of ON-positive rabbits and rates of ON-positive regions were compared using the chi-square test. Differences in laboratory data between the AP and NS groups were analysed by repeated-measures analysis of variance (MANOVA).
If an interaction between two factors of a group and time point was significant in repeated MANOVA, a simple main effect test on the group difference at the same time point was applied. Temporal changes in laboratory data were analysed in each group by the Wilcoxon signed-rank test. Statistical analyses were performed using the JMP 8.0 software package (SAS Institute, Cary, NC, USA). P < 0.05 was considered to be statistically significant.
Results

Incidence of ON
Two rabbits in the AP group died. One of the rabbits died for an unknown reason at 1 day after the MPSL injection, and the other died due to bleeding from the injured site caused by the insertion of a rubber gastric tube 3 days after the injection. No rabbits died in the NS group. The incidence of ON in the AP group was 48.5% (16 out of 33 rabbits), whereas that in the NS group was 73.3% (22 out of 30 rabbits). There was a significant difference in the incidence of ON between the AP and NS groups (P = 0.042). The rate of proximal femur involved in ON in the AP group (42.4%) was significantly lower than that in the NS group (70.0%) (P = 0.027). In other regions, there was no significant difference of the rate of ON between the AP and NS groups.
The histological appearances and severities of ON were similar in the AP and NS groups (Fig. 1A and B) . In the metaphysis and diaphysis of both groups, yellowish ON areas were observed, in which an accumulation of bone marrow cell debris was seen and the bone trabeculae showed empty lacunae.
Platelet aggregation assay
The PATI in the AP group showed a significant increasing tendency after the administration of clopidogrel (Weeks 01, P = 0.001; Weeks 12, P < 0.0001; Weeks 23, P < 0.0001), whereas that in the NS group showed no significant change (Fig. 2A) . The PATI in the AP group was significantly higher than that in the NS group by repeated MANOVA (P < 0.0001) with a significant interaction between the group and time point (P < 0.0001). Based on the simple main effect test, the PATI between two groups were found to be significantly different at Weeks 1, 2 and 3 after the drug administration (Week 1, P = 0.043; Week 2, P < 0.0001; Week 3, P < 0.0001).
Examination of the laboratory data
No significant differences were seen in the levels of triglycerides and total cholesterol between the AP and NS groups (P = 0.44 and 0.47) (Fig. 2B and C) . After MPSL injection, these levels showed similar patterns in both groups. After MPSL injection, the numbers of platelets were significantly decreased in two groups (P = 0.0006 and 0.020) (Fig. 2D) . However, the number of platelets in the AP group remained significantly higher than in the NS group (P = 0.027), especially at Weeks 1 and 2 (P = 0.015 and 0.0046).
Discussion
Anti-thrombotic drugs are generally classified into two types, anti-platelet drugs and anti-coagulant drugs. Antiplatelet drugs are mainly used for the prevention of arterial ischaemic diseases, such as cardiovascular diseases or atherothrombotic stroke through inhibition of platelet aggregation [7] . On the other hand, anti-coagulant drugs are mainly used for prevention of thrombotic diseases, such as coagulation due to atrial fibrillation or deep venous thrombosis by inhibition of clot formation [14] . Anti-coagulant drugs, such as warfarin, have been reported to have preventive effects against steroidinduced ON [3] ; however, there are no reports regarding the effects of anti-platelet drugs on the prevention of steroid-induced ON.
In arterial ischaemic diseases, many reports have demonstrated the crucial role of platelet aggregation resulting from the dysfunction of the endothelium [7] . Kang et al. [15] reported an epidemiological study in which the incidence of coronary heart disease was significantly higher in patients who had avascular necrosis. They suggested that common risk factors between avascular necrosis and coronary heart disease, such as smoking, obesity and hyperlipidaemia, may have been responsible. Kerachian et al. [6] reported that CSs led to the dysfunction of the endothelial cell as well as the regional endothelial bed in the bone vascular system, causing steroid-induced ON. In the present study, we demonstrated the possibility that clopidogrel may be effective for the prevention of steroid-induced ON resulting from the inhibition of platelet aggregation.
Several mechanisms have been implicated in the pathogenesis of steroid-induced ON. Hyperlipidaemia has been identified as an important possible contributor to ON. Jaffe et al. [16] suggested that steroid-induced hyperlipidaemia could increase the amount of fat within the femoral head, elevate intra-cortical pressure and lead to sinusoidal collapse. Wang et al. [17] have undertaken studies to show how altered lipid metabolism might lead to   FIG. 1 Histopathological appearances of an osteonecrotic lesion in the AP (A) and NS (B) groups. Bone trabeculae showed empty lacunae and surrounding bone marrow was necrotic. Neither granulation tissue nor appositional bone formation are obvious between the osteonecrotic (Nec) and living (Liv) bone marrow tissue at 2 weeks after steroid injection in either group (haematoxylin and eosin stained; original magnification Â100).
www.rheumatology.oxfordjournals.org ON. However, in the present study, the levels of triglycerides and total cholesterol showed no differences between the two groups, which at least indicated that the reduction of the incidence of steroid-induced ON was partly achieved by the inhibition of platelet aggregation without any significant effect on the lipid metabolism.
The major limitation of the present study is that there are differences in drug effects and bioavailability between humans and animals. We showed a sufficient effect on the inhibition of platelet aggregation in the animal study based on the previous reports [13] . Secondly, anti-platelet drugs have several side effects, such as excessive bleeding, thrombotic thrombocytopenic purpura and agranulocytosis. In the present study, none of the animals showed such side effects. Clopidogrel was recommended as one of the first choice of drug for management of cardiovascular diseases in the American Heart Association guideline in 2002 because of the efficacy and safety [10] . In addition, recent study reported that concomitant usage of proton-pump inhibitors with clopidogrel reduced the rate of gastrointestinal bleeding without blunting the efficacy [18] . Thirdly, in the present study, the anti-platelet drug alone could not achieve the complete prevention of steroid-induced ON. Some experimental studies have suggested other effective drugs for the prevention of steroid-induced ON, including warfarin, statin and vitamin E [3, 4, 11] . These results may indicate that steroidinduced ON has a multi-factorial pathogenesis including contributions of hyperlipidaemia, coagulation abnormalities, oxidative stress and platelet aggregation. In conclusion, clopidogrel may be useful as one of the possible candidates for the prevention of steroid-induced ON, and further animal studies and eventual human clinical trials are warranted. FIG. 2 The PATI of the whole blood aggregation induced by ADP (A), and haematological parameters of triglycerides (B), total cholesterol (C) and the number of platelets (D). (A) The PATI was calculated to examine the inhibitory effect of platelet aggregation as the concentration of ADP causing a 50% increase in whole-blood aggregation using WBA Carna (IMI). The levels of PATI in the AP and NS groups were significantly different (P < 0.0001, repeated MANOVA). The levels of PATI in the AP group were significantly higher than those in the NS group at each point (Week 1, P < 0.05; Weeks 2 and 3, P < 0.001, simple main effect test). In the AP group, the levels of PATI at Weeks 1, 2 and 3 were significantly higher than that at Week 0 (Week 1, P < 0.01; Weeks 2 and 3, P < 0.001, Wilcoxon signed-rank test). (B, C) The levels of triglycerides and total cholesterol significantly increased after steroid injection (P < 0.0001, Wilcoxon signed-rank test). However, these showed no significant differences between the AP and NS groups (P = 0.44, 0.47, repeated MANOVA). (D) The number of platelets in the AP group was significantly higher than that in the NS group (P = 0.027, repeated MANOVA). The differences were especially significant at Weeks 1 and 2 (P < 0.05, 0.01, simple main effect test). *** *** * *P < 0.05 **P < 0.01 ***P < 0.001 *P < 0.05 **P < 0.01 ***P < 0.001 *P < 0.05 **P < 0.01 ***P < 0.001 *P < 0.05 **P < 0.01 ***P < 0.001 
